Stocks and Investing Stocks and Investing
Wed, April 29, 2020
Tue, April 28, 2020

Graig Suvannavejh Initiated (ADVM) at Strong Buy and Held Target at $170 on, Apr 28th, 2020


Published on 2024-10-27 04:22:14 - WOPRAI, Graig Suvannavejh
  Print publication without navigation


Graig Suvannavejh of Goldman Sachs, Initiated "Adverum Biotechnologies, Inc." (ADVM) at Strong Buy and Held Target at $170 on, Apr 28th, 2020.

Graig has made no other calls on ADVM in the last 4 months.



There are 4 other peers that have a rating on ADVM. Out of the 4 peers that are also analyzing ADVM, 0 agree with Graig's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Graig


  • Mani Foroohar of "SVB Leerink" Initiated at Buy and Held Target at $170 on, Monday, March 16th, 2020
  • Alethia Young of "Cantor Fitzgerald" Upgraded from Hold to Buy and Increased Target to $210 on, Monday, February 10th, 2020
  • Gbola Amusa of "Chardan Capital" Upgraded from Hold to Strong Buy and Increased Target to $200 on, Monday, February 10th, 2020
  • Tyler Van Buren of "Piper Sandler" Reiterated at Buy with Increased Target to $200 on, Monday, January 13th, 2020
Contributing Sources